Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ottavia Prunas"'
Autor:
Ottavia Prunas, Joukje E. Willemsen, Louis Bont, Virginia E. Pitzer, Joshua L. Warren, Daniel M. Weinberger
Publikováno v:
medRxiv
BackgroundTo achieve licensure, interventions typically must demonstrate efficacy against a primary outcome in a randomized clinical trial. However, selecting a single primary outcomea prioriis challenging. Incorporating data from multiple and relate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72be02207183765fb1c179b512844fc4
https://europepmc.org/articles/PMC9934779/
https://europepmc.org/articles/PMC9934779/
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
Background The short-term effectiveness of a 2-dose regimen of the BioNTech/Pfizer BNT162b2 vaccine for adolescents has been demonstrated. However, little is known about the long-term effectiveness in this age group. It is known, however, that waning
Publikováno v:
medRxiv
article-version (status) pre
article-version (number) 1
article-version (status) pre
article-version (number) 1
BackgroundThe short-term effectiveness of a two-dose regimen of the BioNTech/Pfizer mRNA BNT162b2 vaccine for adolescents has been demonstrated. However, little is known about the long-term effectiveness in this age group. It is known, though, that w
Autor:
Tal Patalon, Ottavia Prunas, Daniel M. Weinberger, Sivan Gazit, Joshua L. Warren, Virginia E. Pitzer
With the evidence of waning immunity of the BNT162b2 vaccine, a national third dose vaccination campaign was initiated in Israel during August 2021; other countries have announced their intention to administer a booster shot as well. Leveraging data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::183c1dcff1d5f85e2e6a3bb88c3f1bd0
https://doi.org/10.1101/2021.08.29.21262792
https://doi.org/10.1101/2021.08.29.21262792
Autor:
Ottavia Prunas, Joshua L. Warren, Forrest W. Crawford, Sivan Gazit, Tal Patalon, Daniel M. Weinberger, Virginia E. Pitzer
Publikováno v:
medRxiv
article-version (status) pre
article-version (number) 2
article-version (status) pre
article-version (number) 2
The individual-level effectiveness of vaccines against clinical disease caused by SARS-CoV-2 is well-established. However, few studies have directly examined the effect of COVID-19 vaccines on transmission. We quantified the effectiveness of vaccinat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::937e887ac4cc2fe3324c25888caec85f
https://doi.org/10.1101/2021.07.13.21260393
https://doi.org/10.1101/2021.07.13.21260393
Publikováno v:
American journal of epidemiology. 191(4)
Invasive meningococcal disease (IMD) has a low and unpredictable incidence, presenting challenges for real-world evaluations of meningococcal vaccines. Traditionally, meningococcal vaccine impact is evaluated by predicting counterfactuals from pre-im
Autor:
Tal Patalon, Virginia E. Pitzer, Joshua L. Warren, Daniel M. Weinberger, Ottavia Prunas, Sivan Gazit
Publikováno v:
JAMA Intern Med
Importance With the evidence of waning immunity of the mRNA vaccine BNT162b2 (Pfizer-BioNTech), a nationwide third-dose (booster) vaccination campaign was initiated in Israel during August 2021; other countries have begun to administer a booster shot